Foghorn Therapeutics Inc.
FHTX | NASDAQ
$4.15
+$0.01 (+0.24%)
At close: Sep 21, 2026, 4:00 PM ET
$4.25
+$0.10 (+2.41%)
After-hours:
Sep 21, 2026, 7:41 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 30.91M | 22.6M | 34.16M | 19.23M | 1.32M | 430K |
Cost of Revenue | 3.33M | n/a | n/a | n/a | n/a | 57.72M |
Gross Profit | 27.58M | 22.6M | 34.16M | 19.23M | 1.32M | -57.29M |
Operating Income | -82.11M | -102.68M | -107.91M | -117.14M | -100.73M | -68.53M |
Interest Income | 8.75M | 11.9M | 10.88M | 5.68M | 59K | 1M |
Pretax Income | -74.28M | -86.62M | -94.2M | -108.88M | -101.32M | -68.8M |
Net Income | -74.28M | -86.62M | -98.43M | -108.88M | -101.32M | -68.8M |
Selling & General & Admin | 27.55M | 28.36M | 32.37M | 30.75M | 21.73M | 11.25M |
Research & Development | 85.47M | 94.53M | 109.69M | 105.62M | 80.33M | 57.72M |
Other Expenses | -3.33M | 2.4M | n/a | n/a | n/a | -57.72M |
Operating Expenses | 109.68M | 125.29M | 142.06M | 136.37M | 102.05M | 11.25M |
Interest Expense | n/a | n/a | n/a | n/a | 1.91M | 979K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 113.02M | 125.29M | 142.06M | 136.37M | 102.05M | 68.96M |
Income Tax Expense | n/a | n/a | 4.23M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.98M | 54.9M | 41.97M | 41.59M | 37.17M | 36.79M |
Shares Outstanding (Diluted) | 62.98M | 54.9M | 41.97M | 41.59M | 37.17M | 36.79M |
EPS (Basic) | -1.18 | -1.58 | -2.34 | -2.62 | -2.78 | -1.90 |
EPS (Diluted) | -1.18 | -1.58 | -2.34 | -2.62 | -2.78 | -1.90 |
EBITDA | -70.95M | -97.17M | -90.75M | -105.56M | -96.19M | -67.2M |
EBIT | -74.28M | -100.29M | -94.2M | -108.88M | -99.41M | -68.53M |
Depreciation & Amortization | 3.33M | 3.12M | 3.45M | 3.32M | 3.23M | 1.33M |
Add to Watchlist
Select watchlists to add or remove FHTX